Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C2 | P08235 | 7/20 | 0.49 |
| ▸ | MMP12 | P39900 | 1/20 | 0.49 |
| ▸ | PKM | P14618 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | PARP1 | P09874 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.42 |
| ▸ | PGR | P06401 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30954152 | 1.00 | NR3C2 (0.49) | NR3C2MMP12PKMMAPTPOLB | |
| SCHEMBL23830907 | 0.94 | NR3C2 (0.49) | NR3C2MMP12PKMMAPTPOLB | |
| SCHEMBL27434479 | 0.83 | PKM (0.57) | MMP12PKMMAPTPOLBALDH1A1 | |
| SCHEMBL4049030 | 0.82 | MMP12 (0.54) | NR3C2MMP12PKMMAPTALDH1A1 | |
| SCHEMBL2945841 | 0.81 | MMP12 (0.46) | NR3C2MMP12PKMMAPTPOLB | |
| SCHEMBL2947630 | 0.80 | PKM (0.54) | MMP12PKMMAPTPOLBALDH1A1 | |
| SCHEMBL19833946 | 0.79 | LMNA (0.55) | NR3C2MMP12PKMMAPTPOLB | |
| SCHEMBL13382354 | 0.79 | TP53 (0.60) | MMP12PKMMAPTPOLBALDH1A1 | |
| SCHEMBL30659575 | 0.79 | MMP12 (0.49) | MMP12PKMMAPTPOLBALDH1A1 | |
| SCHEMBL20373267 | 0.79 | MMP12 (0.49) | MMP12PKMMAPTPOLBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630412-A1 | COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | NMD Pharma A/S (DK) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024121130-A1 | COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | NMD PHARMA A/S (DK) | 2024-06-13 | — | — | WO | disclosed |
| WO-2024121130-A1 | COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | NMD PHARMA A/S (DK) | 2024-06-13 | — | — | WO | disclosed |